摘要
Dapagliflozin(DAP) is a potent and selective sodium-glucose contransporter-2(SGLT-2) inhibitor, and performed as an efficacious treatment for type 2 diabetes. Sever hygroscopicity of DAP hinder the usage of its free form during process of pharmaceutical production. A solvate form(dapagliflozin propanediol, DAP-PDO-H_2O) is used in the market, which, however, also faces problem of thermal instability as higher vapor pressure of solvent molecules in crystal lattice. The present study obtained a new cocrystal of DAP with citric acid(DAP-CA). DAP-CA cocrystal was identified and characterized by ~1H nuclear magnetic resonance(~1H-NMR), Fourier transform infra-red spectroscopy(FTIR), powder X-ray diffraction(PXRD) and thermal analysis, It was also evaluated by dynamic vapor sorption(DVS) and accelerated stability test under 40 ℃/75% RH, as well as powder dissolution test. DAP-CA cocrystal showed enhanced stability against both humidity and high temperature compared to the market form without compromising the dissolution solubility.
Dapagliflozin(DAP) is a potent and selective sodium-glucose contransporter-2(SGLT-2) inhibitor, and performed as an efficacious treatment for type 2 diabetes. Sever hygroscopicity of DAP hinder the usage of its free form during process of pharmaceutical production. A solvate form(dapagliflozin propanediol, DAP-PDO-H_2O) is used in the market, which, however, also faces problem of thermal instability as higher vapor pressure of solvent molecules in crystal lattice. The present study obtained a new cocrystal of DAP with citric acid(DAP-CA). DAP-CA cocrystal was identified and characterized by ~1H nuclear magnetic resonance(~1H-NMR), Fourier transform infra-red spectroscopy(FTIR), powder X-ray diffraction(PXRD) and thermal analysis, It was also evaluated by dynamic vapor sorption(DVS) and accelerated stability test under 40 ℃/75% RH, as well as powder dissolution test. DAP-CA cocrystal showed enhanced stability against both humidity and high temperature compared to the market form without compromising the dissolution solubility.
引文
[1]Chen,J.M.,Wang,Z.Z.,Wu,C.B.,et al.Crystal engineering approach to improve the solubility of mebendazole,Cryst Eng Comm.2012,14,6221-6229.
[2]Desiraju G.R.,Crystal Engineering:From Molecule to Crystal,J.Am.Chem.Soc.2013,135,9952-9967.
[3]Wang Z.Z.,Chen J.M.,Lu T.B.,Enhancing the Hygroscopic Stability of S-Oxiracetam via Pharmaceutical Cocrystals.Cryst.Growth Des.2012,12,4562-4566